International MPN News, Science & Opinion

ASH 2014 SNAPSHOT: Dr. Elizabeth Trehu and PRM-151

 It’s going to take a lot more than the clatter of a kitchen cart to keep Dr. Elizabeth Trehu from presenting the long-awaited  results of the PRM-151 and Ruxolitinib clinical trial for myelofibrosis patients.  In this impromptu interview conducted in a hotel corridor at ASH, Trehu traces the origin of the project, summarizes the results and talks about plans for the next stage of the PRM-151 trial in her short video, below.

Dr. Elizabeth Trehu, Chief Medical Officer. Promedior

Dr. Elizabeth Trehu, Chief Medical Officer. Promedior

 

The MD Anderson Report on PRM-151 Results

 

MD Anderson on PRM 151

Take me back to the Contents

©  2014, MPNforum, LLC . Unauthorized use and/or duplication of this material without express and written permission is prohibited. Excerpts and links may be used, provided that full and clear credit is given to MPNforum.com with appropriate and specific direction to the original content. All rights reserved under Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

Comments on: "ASH 2014 SNAPSHOT: Dr. Elizabeth Trehu and PRM-151" (1)

  1. Pauline Schreffler said:

    I so hope to be able to try this promising therapy. I have MF with a lot of fibrosis & enlarged spleen. Plan on arranging an appointment with Dr. Mesa at Mayo in Scottsdale.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: